HealthWell Foundation launches fund for underinsured multiple myeloma patients

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE HEALTHWELL FOUNDATION launched a fund to provide financial assistance to underinsured patients suffering from multiple myeloma, providing grants up to $10,000 to assist patients with copayment or premium costs.

Multiple myeloma patients who are insured and have annual household incomes up to 500 percent of the federal poverty level are eligible under the fund. http://www.HealthWellFoundation.org

“A substantial number of multiple myeloma patients face significant hardship when it comes to treatment choices and the ability to cover out-of-pocket drug copayment and premium expenses,” said Sharon Saias, Vice President Marketing and Communications, Multiple Myeloma Research Foundation. “The financial lifeline being offered through the HealthWell Foundation addresses a critical need for these patients and allows them to access medical treatments that are vital to managing their disease.”

Table of Contents

YOU MAY BE INTERESTED IN

Shearwood McClelland III’s grandfather was a ditchdigger who dreamed that his six Black daughters would become doctors. McClelland’s mother did not disappoint—she became the first Black woman board-certified in maternal fetal medicine in the history of the United States.  Now, McClelland is the chief medical officer of Cancer Health Equity at the University of Oklahoma...

As oncology enters a new era of precision medicine, the Food and Drug Administration’s evolving biomarker strategy aims to ensure that life-saving therapies are tailored to individual patient needs, fostering safer and more effective treatments.  Historically, therapies were approved with broad indications based on overall efficacy, even when outcomes for biomarker-positive and -negative patients were...

In the evolving landscape of pediatric oncology, survivorship research has become an essential component of our mission to improve long-term patient outcomes. At City of Hope, we are focused on not only curing childhood cancers but also ensuring that survivors live the healthiest lives possible. A significant part of my research has been dedicated to mitigating the long-term toxicities of cancer therapy—particularly cardiovascular complications that can arise decades after treatment.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login